Moderna says COVID-19 vaccine generates 'robust' response in kids 6-11

Moderna’s COVID-19 vaccine generated a “robust” neutralizing antibody response in children ages 6 to 11, the company said Monday.

Fauci: COVID-19 vaccines for younger kids could come as early as November

Dr. Anthony Fauci said Sunday that COVID-19 vaccines could “be available for children from five to 11 within the first week or two of November.”

Unvaccinated people can expect COVID-19 infections every 16 months, study suggests

Unvaccinated people are at risk of being reinfected with COVID-19 every 16 months, according to a new study conducted by the Yale School of Public Health.

South Africa tries to end vaccine inequity by replicating Moderna shot

A team of young scientists in South Africa is assembling the equipment needed to reverse engineer Moderna's coronavirus vaccine.

California hiring slows in September; jobless rate at 7.5%

In California, new coronavirus cases are at their lowest point since the start of the pandemic, schools have fully reopened and the more generous unemployment benefits from the federal government have expired — all signs of what should have been a robust economic recovery in September.

Pfizer says COVID-19 vaccine more than 90% effective in kids 5-11

Pfizer says its COVID-19 vaccine is more than 90% effective at protecting elementary school-age kids from infection, ahead of a public review.

COVID-19 vaccines: CDC OKs Moderna, J&J and mix-and-match boosters

The CDC has signed off on Moderna and J&J COVID-19 booster shots. The agency is allowing the flexibility of “mixing and matching" the extra dose.

Chino Valley Unified meets to discuss vaccines
video

Hundreds of parents packed inside a school board meeting in Chino demanding officials to not enforce a vaccine mandate on kids.

COVID-19 outbreak among students forces closure of LA County school

View Park Preparatory Accelerated Charter High School shuttered its campus for the entire week, returning to remote learning out of an abundance of caution after more than a dozen students tested positive for COVID-19.

Pfizer says COVID-19 booster restores vaccine efficacy to 95.6%

Pfizer shared results from its Phase 3 trial of its COVID-19 vaccine booster, saying the third dose showed 95.6% efficacy against symptomatic disease.

Pregnant women express regret about not getting COVID-19 vaccine

Two women from Georgia and Alabama who contracted COVID-19 during their pregnancies are urging other pregnant women to get vaccinated.